Cargando…

Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events

AIMS: To determine whether changes in practice, over time, are associated with altered rates of major bleeding in acute coronary syndromes (ACS). METHODS AND RESULTS: Patients from the Global Registry of Acute Coronary Events were enrolled between 2000 and 2007. The main outcome measures were freque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Keith A.A., Carruthers, Kathryn, Steg, Ph. Gabriel, Avezum, Álvaro, Granger, Christopher B., Montalescot, Gilles, Goodman, Shaun G., Gore, Joel M., Quill, Ann L., Eagle, Kim A.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838680/ https://www.ncbi.nlm.nih.gov/pubmed/20007159 http://dx.doi.org/10.1093/eurheartj/ehp499

Ejemplares similares

GRACE (the Global Registry of Acute Coronary Events): the real world side of the cardiovascular clinical practice in acute coronary syndromes
por: Knobel, M, et al.
Publicado: (2001)

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: Bossard, Matthias, et al.
Publicado: (2017)

Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial
por: Everett, Colin C, et al.
Publicado: (2019)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
por: Pham, Phuong-Anh, et al.
Publicado: (2011)

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015)

Acute Multivessel Coronary Occlusion Revealing COVID-19 in a Young Adult
por: Zendjebil, Sandra, et al.
Publicado: (2020)

Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score
por: Fox, Keith A A, et al.
Publicado: (2014)

Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry
por: Mehta, Rajendra H., et al.
Publicado: (2008)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization
por: Udell, Jacob A., et al.
Publicado: (2017)

Global Registry of Acute Coronary Events Score Underestimates Post-Acute Coronary Syndrome Mortality among Cancer Patients
por: Koo, Chieh-Yang, et al.
Publicado: (2023)

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017)

Acute Coronary Syndrome in Young Adults from Oman: Results from the Gulf Registry of Acute Coronary Events
por: Panduranga, Prashanth, et al.
Publicado: (2010)

Alirocumab after acute coronary syndrome in patients with a history of heart failure
por: White, Harvey D, et al.
Publicado: (2021)

Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
por: Eisen, Alon, et al.
Publicado: (2016)

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Guedeney, Paul, et al.
Publicado: (2020)

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
por: Lindholm, Daniel, et al.
Publicado: (2017)

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes
por: Verheugt, F. W. A.
Publicado: (2013)

Bleeding risk assessment in elderly patients with acute coronary syndrome
por: Riobóo-Lestón, Lucía, et al.
Publicado: (2019)

Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2019)

Interleukin‐18 in patients with acute coronary syndromes
por: Åkerblom, Axel, et al.
Publicado: (2019)

Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry
por: Lin, Tsung-Hsien, et al.
Publicado: (2014)

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry
por: van der Sangen, Niels M R, et al.
Publicado: (2023)

Safety of gastrointestinal endoscopy in patients with acute coronary syndrome and concomitant gastrointestinal bleeding
por: Elkafrawy, Ahmed A, et al.
Publicado: (2021)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
por: Tersalvi, Gregorio, et al.
Publicado: (2020)

Risk Factors for Acute Coronary Syndrome in Upper Gastrointestinal Bleeding Patients
por: Chi, Tianyu, et al.
Publicado: (2021)

International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19
por: Kite, Thomas A., et al.
Publicado: (2021)

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
por: Sinnaeve, Peter R, et al.
Publicado: (2020)

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis
por: Bellemain-Appaix, Anne, et al.
Publicado: (2014)

The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
por: McCarthy, Cian P, et al.
Publicado: (2017)

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial
por: Fudim, Marat, et al.
Publicado: (2021)

Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial
por: Gale, Chris P, et al.
Publicado: (2023)

Coronary angiography in patients with acute heart failure: from the KCHF registry
por: Seko, Yuta, et al.
Publicado: (2021)

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP–GPRD)
por: Boggon, Rachael, et al.
Publicado: (2011)

The Bleeding Risk Score as a Mortality Predictor in Patients with Acute Coronary Syndrome
por: Nicolau, José Carlos, et al.
Publicado: (2013)

A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes
por: Alkhalil, Mohammad, et al.
Publicado: (2022)

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
por: Steg, Ph. Gabriel, et al.
Publicado: (2011)

Acute coronary syndromes
por: Bergmark, Brian A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kj09uhk3q1ei9tqrlr4qftk0ee